Windtree Therapeutics Inc. (WINT)
Market Closed
16 Jun, 20:00
OTC PINK OTC PINK Primary $
0. 02
-0
-10%
$
539.34K Market Cap
- P/E Ratio
- Div Yield
3,846 Volume
- Eps
$ 0.02
Previous Close Want to track WINT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?
Windtree Therapeutics (NASDAQ: WINT ) stock is rocketing higher on Friday after the biotechnology company provided an update on its clinical trial of istaroxime. Windtree Therapeutics notes that it is expecting its Phase 2 Phase 2 SEISMiC Extension Study to complete enrollment within the company weeks.
Investorplace | 1 year ago
